Form D — GeneCentric Therapeutics, Inc.
0001529224-25-000001 · filed Jun 20, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $5,000,000
- Reported amount sold
- $1,999,967
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- GeneCentric Therapeutics, Inc.
- CIK
- 1529224
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 100 CAPITOLA DRIVE
DURHAM, North Carolina 27713 - Phone
- (919) 973-6544
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
MICHAEL MILBURN · Executive OfficerDurham, North Carolina Find on LinkedIn ↗
-
CLAY THORP · DirectorDurham, North Carolina Find on LinkedIn ↗
-
ARNOLD LEVINE · DirectorDurham, North Carolina Find on LinkedIn ↗
-
MYLA LAI-GOLDMAN · DirectorDurham, North Carolina Find on LinkedIn ↗
-
CHARLES PEROU · DirectorDurham, North Carolina Find on LinkedIn ↗
-
Don Hardison · DirectorDurham, North Carolina Find on LinkedIn ↗
-
Prasanth Reddy · DirectorDurham, North Carolina Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗